ABSTRACT
RÉSUMÉ CONTEXTE: L'utilité des rapports est l'histopathologie en fonction de la qualité des informations qui y sont contenues. Ainsi il est nécessaire d'établir des critères minimaux à remplir signaler les cas comme un mécanisme de contrôle de la qualité. OBJECTIF: vérification de la qualité des rapports d'histopathologie mastectomie spécimens reçus dans le laboratoire de pathologie de un hôpital d'enseignement. MÉTHODES: numéros d'Laboratoire de tous portant le cancer cas de mastectomie a reçu en 10 ans (1999-2008) ont été extraites de registres de réception et de leur pathologie d'accompagnement des cartes demande initiale ont été extraites de archives. A partir de ces cartes réunion d'information pertinentes six fois les critères de vérification
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INTRODUCTION
The need for Clinical Audit as a tool for ensuring quality of laboratory output in laboratories has been well recognized. 1 The benefits to the practice of laboratory medicine and improved patient care are also indisputable. Yet most laboratories in Nigeria have failed to implement a structured audit scheme to give life to this concept. 2 The first historically documented audit activity in clinical practice is credited to Florence Nightingale during the Crimean War of 1853-1855.
3 Appalled by the high mortality rates in the military hospital she employed a methodical approach to patient care as well as laying emphasis on uniformity and comparability of results of health care. With this change in approach she lowered mortality from 40% to 2%.
3 Another historical figure worthy of mention is Ernest Codman, an American. He is reported to be the first true medical auditor following his work in 1912 on monitoring surgical outcomes. He envisioned quality monitoring and assurance for efficient patient management.
3
The definition, concept and prefixes attached to the word "Audit" relative to medical practice have evolved over the years. In 1989, in the United Kingdom, following recognition of the need to integrate audit activity into medical practice a White Paper entitled Working for patients was released. In this paper the term "medical audit" was introduced, and it was defined as: The process of Clinical audit is a cyclical or spiral pattern and involves five important steps: 6 (1) identification of a problem or issue. This may be accomplished by collective brainstorming by stakeholders as well as collection of data on past practice; (2) criteria and standards definition. These serve as the yard stick against which future performances are evaluated; (3) observation and data collection of ongoing practice; (4) comparison of performance with established standards. The improvements noted in practice relative to set standards however have been shown to exhibit the Hawthorn effect 7 which attributes improvement in practice to the awareness of being observed during data collection. This has been shown to be minimal if data collection is subtle and attention is not deliberately drawn to the audit activity; 8 and (5) implementation of changes. Following implementation of changes the cyclical process recommences. The effectiveness of clinical audit has been shown to be more obvious the further the current practice is from the set standards. 6 This study aimed to audit the quality of information contained in the histopathology reports of mastectomy specimens received in the Pathology laboratory of Aminu Kano Teaching Hospital, Kano between 1st January, 1999 and 31 st December, 2008 and to establish a baseline for comparison of future clinical audit activities.
MATERIALS AND METHODS
Location of study: This audit activity was carried out in the Histopathology Department of Aminu Kano Teaching Hospital, Kano, Northwestern Nigeria and it spans a period of 10 years (1999 -2008) .
Choice of indicators: The choice of six criteria utilized in this audit activity is based on results of literature search. 9, 10 These items, with the exception of immunohistochemcal assessment omitted in this study because it has only recently become available, have been shown to be vital in the management of patients with breast cancer. Thus these were assessed for their inclusion in histopathology reports for the years under review in addition to assessment of the laboratory's turn-around-time. The seven parameters included: tumour size in at least one dimension; distance of tumour from at least one resection margin; histologic tumour type; histologic grading (modified Blooms and Richardson); presence or absence of lymphatic and/or vascular invasion; histologic status of the resection margins; and the turn around time.
Inclusion and exclusion criteria: All simple, modified radical and radical mastectomy specimens were included in the audit while all specimens from lumpectomy, quadrantectomy, segmental resection, partial mastectomy, tylectomy and residual tumour were excluded. Cases with missing archival material were also excluded from the audit.
Data Retrieval: Cases meeting the inclusion criteria were obtained from the departmental specimen register and original forms accompanying them were retrieved from archives. From these forms data were extracted on the completeness of the macroscopic and microscopic information provided relative to the set audit criteria.
Number Analyzed: One hundred and sixty-five specimens meeting the inclusion criteria were received and analyzed during the 10-year period but complete archival records were available for only 134 (81.2%) cases. Data management and analysis was done with SPSS 16.0 version.
RESULTS
In the period covered by this audit 165 mastectomy specimens meeting the inclusion criteria were retrieved but records were available for only 134 (81.2%). The annual number of mastectomy cases increased progressively from five in 1999 to 24 in 2008 As shown in Table 1 the most frequently mentioned feature in the surgical pathology reports was the histologic tumour type described in 123 (92%) of cases while the least mentioned feature was presence or absence of vascular or lymphatic invasion. Tumour size was measured in only 67 (50%) cases, macroscopic resection margin, aided by painting or tagging, in 83 (62%), microscopic resection margin in 86 (64%) and histologic grading in 53 (40%) cases. Only 3 (2.2%) of all our reports met all the requirements of the audit criteria. Annual mean turn around time ranged from 6.2 -22.7 days with an overall average of 15.8 days. No remarkable temporal trends were noted in the documentation of any of these parameters in the ten years studied.
DISCUSSION
The necessity for continuous clinical audit in anatomic pathology or histopathology and cytopathology cannot be overemphasized. In Nigeria the Medical and Dental Council of Nigeria (MDCN) is the body charged with the responsibility of monitoring laboratory performance but as noted by Ojo et al 2 the practice of clinical audit is yet to be entrenched in pathology laboratory set up nation-wide.
The implementation of sustainable clinical audit mechanisms in any laboratory would primarily require a thorough assessment of its performance in the years preceding the setting of standards. 6 This would enable it to identify its strengths and weaknesses and thus be able to determine areas on which to focus its corrective strategies. The ultimate focus of such a laboratory would be improved and sustainable quality of service to its clients, the clinicians. It may require the laboratory to identify those aspects of its services that are most frequently demanded by its clients or those in which laboratory errors are associated with grievous consequences. The choice to highlight the quality of breast cancer reports that have emanated from our histopathology laboratory in AKTH stems from this need for quality assurance.
Breast cancer has become the most common female cancer worldwide and in parts of Nigeria it is competing strongly in ranking with cervical cancer as the most common female cancer. 11, 12 Thus the need to standardize histopathology reports so as to ensure that information contained therein is promptly delivered and of clinical relevance for optimum patient care.
Breast cancer pathology reporting has been found to be associated with wide inter-laboratory variations. 13 Key elements that affect treatment are sometimes not included in these reports and these often contribute to delays in and suboptimal patient management. 13 The recognition of these variations in reporting has led to the adoption of standardized formats as instruments of quality control and assurance. The need for such quality control measures resulted in formulation of specific recommendations for breast cancer reporting by the Australian Cancer Network in 1995 and similarly led the Breast Tumor Panel of the Canadian Reference Centre for Cancer Pathology in the same year to distribute guidelines for reporting cancer specimens. 14, 15 Relative to what obtains in developed countries our laboratory is currently at a stage comparable to that in most laboratories in Australia in 1995 before the release of specific recommendations for breast cancer reporting. Prior to the release of the recommendations tumour type and size were found to be given in reports of invasive breast cancer for 93% of women, 70% had, in addition, grade and clearance of the margins while only 28% had all recommended information. 16 In comparison our reports documented tumour type in 92% of cases but only documented tumour size in 50% of cases. The presence or absence of tumour cells in the resection margin, which determines the completeness or otherwise of surgical procedure, was documented in only 64% of our cases. Only 3 (2.2%) of all our reports met all the requirements of the audit criteria. While tenable the observation that as a tertiary hospital laboratory trainee pathologist may be responsible for several of these omissions, it only serves to buttress the need to develop standardized formats for reporting of specific disease entities as well as ensuring competence of the trainees before being left to function on their own.
In none of the 134 mastectomy specimens audited in this study was the resection margin painted nor specimen oriented. Similar clinical omission was identified in 75% of specimens in an audit of cases in Buffalo, USA.
13 Such omissions have also been shown to negatively limit the usefulness of pathology reports.
The usefulness of pathology reports rely mainly on the information contained in them yet prompt delivery of such reports is of no less significance. The promptness of report delivery determines not only the rapidity with which clinical decisions can be made but also by extension the lengths of patient hospital stay. These clinical considerations are in part governed by the laboratory turn around time. An average TAT of 15.8 days was found for our mastectomy specimens. This is over twice the maximum duration stipulated in the Service Delivery Charter document drawn up by the department for all surgical pathology specimens. The shortest average yearly turn around time our laboratory achieved for mastectomy specimens was 6.2 days. Factors responsible for this include peculiar inherent and extraneous laboratory inputs.
Our centre, for most of the 10 audited years had two full-time Pathologists, four trainee pathologists, two Technologists and one typist. Most of the delays in our centre which is semiautomated have been attributed to poor power supply needed to run various stages of the tissue processing including typing of results which accounted for most of the delay. Inadequate and improperly filled request forms have also constituted another cog in the wheel of prompt service delivery in our centre. Malami 13 relating their findings of falling compliance with College of American Pathologists guidelines in the United States, however caution that passive distribution alone might not be sufficient to accomplish laboratory-wide quality improvement in breast pathology reporting. They concluded that even though it is important to ensure all pathologists adhere to these report formats there is a need to put mechanisms in place to monitor compliancAs similar suggestion was also made by Appleton and colleagues 18 about the need for continuous monitoring of standards as these may deteriorate over time.
Recommendations
For the improvement of quality of histopathology report for breast cancer (and all pathology reports in general) in laboratories across the country it is necessary to implement the following steps:
• Close monitoring of trainee Pathologists by senior colleagues in the various accredited centres.
• Close collaboration between Pathologists and Surgeons to ensure internal quality assurance.
• Close collaboration between laboratories within and outside Nigeria to facilitate inter-laboratory quality assurance
• Need for pathologists to formulate minimal criteria for histopathological reports of breast cancers and other tumours. This could be done by the Association of Pathologists of Nigeria (ASOPON) or the National Postgraduate Medical College of Nigeria (NPMCN) which would require periodic evidences of participation in clinical audit by each fellow of the college of Pathologists.
In conclusion this 10-year audit of histopathology reports of mastectomy specimens from invasive breast cancers in AKTH, Kano has shown the need for establishment of standard report formats as tools of quality assurance, the need for provision of better working conditions in Nigerian laboratories to ensure short turn around times and the need for better record keeping for ease of retrieval.
